Two studies showcase molecular testing advancements in women's health, highlighting improved diagnosis and treatment for infectious diseases and cancer. The research reveals new insights into antimicrobial resistance, cancer recurrence risks, and tumor biology.
The Advanced Practitioner Society of Hematology and Oncology (APSHO) has launched two new educational courses for advanced practitioners in oncology care, developed in collaboration with The Hope Foundation for Cancer Research. The self-paced online courses provide practical, evidence-informed education focused on real-world clinical p...
A new study published in JNCCN found that comprehensive biomarker testing before treatment for advanced lung cancer was associated with patients living longer. Broad-based genomic sequencing helped identify a wider range of tumor biomarkers, guiding targeted treatment and improving survival outcomes.
Researchers created a single-cell atlas for lung cancer, linking it to clinical data to identify tumor cell types that contribute to metastases and predict interactions between tumor cells and their environment. The study predicts clinical outcomes significantly better than traditional parameters.
Scientists identify chimeric RNA molecules as essential in cellular health and disease, finding they play a wide variety of critical roles in vital cellular processes. Faulty chimeric RNA are often malfunctioning in breast cancer tumors, prompting new cancer treatments targeting specific chimeras.
A study found that metformin kills cancer cells by blocking a mitochondrial-cytosolic circuit that drains surplus NADH, reducing reductive stress. The circuit, involving pyruvate carboxylase, mitochondrial malate dehydrogenase, and malic enzyme 1, is a key player in cancer cells' ability to survive under metabolic stress.
The study found that a salt-triggered gel containing engineered Salmonella reduced tumour growth by shrinking tumours as well as free bacteria, cutting weight loss by 82% and reversing liver and spleen damage. The gel also delivered the bacteria to the tumours, avoiding poisoning, and showed promise in treating melanoma and other cancers.
Tracking hCG levels over time helps clinicians assess disease risk, guide treatment decisions, and detect possible relapse. Regular monitoring also supports early detection and timely intervention, even after treatment.
A recent study developed an AI framework, MENISA, combining CT scans, digital tissue images, and tumor microenvironment clues to estimate survival risk in esophageal squamous cell carcinoma patients. The model distinguished groups with different survival outcomes and performed better than models relying on single information sources.
Jennifer Frederick, an oncology clinical trial organizer at Wash U Medicine, received the 2026 Alliance Clinical Research Professionals Research Integrity Service Award for her dedication to helping cancer patients access clinical trials. Her work ensures that trials run smoothly and safely, with a focus on patient advocacy and compass...
A new study found that chemical concentrations in NYC nail salons can spike repeatedly throughout the workday, revealing potential health risks that traditional exposure assessments may overlook. The study highlights the need to incorporate peak-based metrics alongside full-shift averages when evaluating nail salon exposures.
Dr. Susan Bullman receives the 2027 Mary Beth Maddox Award for her pioneering research on tumor microbiome interactions, uncovering how bacteria influence cancer development, treatment response, and immune function. Her work holds promise for developing new bacteria-based cancer therapies.
The National Comprehensive Cancer Network (NCCN) has signed an agreement with the Viet Nam National Cancer Hospital to expand cancer care resources in Vietnam. The collaboration aims to improve cancer care through the adaptation and use of evidence-based clinical practice guidelines.
Simple automated text reminders and personalized telephone support increased bowel cancer screening uptake among non-responders in London, with 6.5% of initial non-responders completing their test kits. The interventions detected an additional 50 extra cancers annually, bridging the eight-percentage-point gap with the national average.
A new study found associations between coagulation-related genes and lung cancer survival, with varying prognostic significance depending on mutation status and tumor location. The research identified four genes, F2, F5, PROS1, and SERPINC1, which may provide additional information for understanding lung cancer prognosis.
JMIR Cancer is calling for research on prostate cancer, focusing on digital health innovations, patient perspectives, and AI advancements. Researchers and patients are encouraged to submit their work on topics such as teleoncology, mobile apps, and personalized treatment planning.
A genetic score from 11 variants identified individuals whose gastric cancer risk dropped 56-80% after H. pylori eradication, reducing the number needed to treat from 112 to 43. The score also sorted treatment effects, pointing to closer surveillance for moderate-benefit individuals.
The Alliance for Clinical Trials in Oncology is highlighting eight ongoing clinical trials focused on improving cancer detection, treatment, and survivorship for men's cancers. These trials aim to enhance quality of life and support patients and their loved ones after treatment.
This review systematically elucidates the interconnected interplay between the tumor microenvironment and macroenvironment, regulating metabolic reprogramming in tumor cells. Emerging precision therapeutic strategies targeting metabolism, such as nanotechnology and exercise, are proposed to develop more effective holistic treatment str...
A newly discovered pathway helps cancer cells selectively produce proteins that drive tumor growth, including KRAS. Targeting the METTL13 enzyme may improve responses to targeted therapies and help overcome treatment resistance.
Researchers have engineered CAR-T cells that target brain tissue, allowing them to selectively destroy tumor cells in pediatric brain cancer DMG. The new therapy, B-SYNC CAR-T, has shown promise in laboratory tests, with the cells persisting and fighting cancer for over 70 days.
Francis Peyton Rous identifies transmissible cancer agent in chickens, challenging established ideas about cancer. His discovery leads to the development of viral oncology and modern understanding of cancer as a genetic disease.
A new study published in NEJM Evidence found that colorectal cancer rates are rising across younger and older age groups, with younger adults now at the highest risk. The study found that the age-adjusted incidence rate fell in the early 2000s but rose to 38.3 in 2023, with the sharpest increase among 45-49-year-olds. The researchers w...
The updated guideline recommends moderate hypofractionation over conventional fractionation for patients across all prostate cancer risk groups who choose EBRT, supported by high-quality randomized data showing comparable outcomes, side effects and quality of life. Ultrahypofractionation is also strongly recommended as a standard optio...
GradientScreen, a 'lab-on-a-chip,' measures how a patient's leukemia cells respond to various drug combinations before treatment starts. This technology helps clinicians identify which patients are likely to be unresponsive to standard treatment and personalize treatment approaches.
The new NCCN Guidelines for Patients: Caregiving for People with Cancer offer concrete tips for handling difficult situations and provide concrete support for caregivers. The guide includes a chapter dedicated to the caregiver's own wellbeing, emphasizing the importance of self-care and providing trusted, easy-to-find information.
The case report highlights the challenges of monitoring residual disease in stage IIIc colon cancer, where conventional imaging shows no measurable tumor but circulating tumor DNA and DNA methylation patterns suggest molecular residual disease. Molecular profiling and international collaboration may help guide treatment decisions in su...
Targeting fat cells with sphingosine kinase 2 inhibitors could be a new strategy to combat obesity and lower the risk of its comorbidities like cancer. The researchers found a significant reduction in body weight, improved glucose tolerance, and reduced lipid accumulation in the liver.
A new analysis of a phase 3 clinical trial found that daraxonrasib improved survival compared with standard chemotherapy across multiple groups of patients with advanced pancreatic cancer. The treatment consistently provided a benefit regardless of tumor RAS mutation status or previous treatment history.
A 55-year-old man with glioblastoma exhibiting amplifications in MDM2 and EGFR genes underwent comprehensive genomic profiling and an international molecular tumor board. The case highlights the potential for precision oncology to identify potential treatment strategies for aggressive brain cancer.
A new study by the University of Pittsburgh found that patients who received earlier survivorship care had better outcomes, including lower recurrence and death rates, compared to those who received care later. The study suggests that timing of survivorship care can be modified to improve patient outcomes.
A case report describes a patient who developed toxic epidermal necrolysis after combination therapy with pembrolizumab and enfortumab vedotin for metastatic urothelial carcinoma. The patient's high-grade urothelial carcinoma and recent radiotherapy may have contributed to the severe skin reaction.
Researchers found quercetin slowed lung cancer cell division and reduced oxidative stress, while increasing Interferon-alpha-2 and gut microbiome, suggesting a potential quercetin-rich diet for lung cancer treatment and prevention
A new review examines how gut microbiota and metabolites reshape liver immunity and propose strategies to overcome immunotherapy resistance. The review discusses four major directions of gut microbiota intervention, including probiotics, fecal microbiota transplantation, engineered bacteria, and metabolite-based interventions.
Insilico Medicine has achieved the early drug discovery milestone in its multi-year AI-driven drug discovery collaboration with Servier, triggering an undisclosed milestone payment. The milestone triggers an undisclosed payment from Servier to Insilico, following the successful fulfillment of predefined program criteria.
A new study found that adding 3D goggles to deep-inspiratory breath-hold radiotherapy did not significantly reduce treatment time. However, setup time was longer when goggles were used, and treatment efficiency improved with repeated sessions.
Researchers at ULiège are developing AI models to predict which HPV infections will progress to cancer, integrating biological data and aiming for more personalized care. Despite significant progress, no current biomarker allows for reliable prediction, and the complexity of HPV carcinogenesis poses a major challenge.
A study published in Cancer Discovery found that cabergoline reduced breast cancer risk by 70% in women who took the medication after childbirth. The drug may also enhance the natural process of breast involution, which can help prevent cancer.
A recent study found that paid family and medical leave policies are widely available but inconsistently implemented across US academic radiology and radiation oncology departments. Most programs require faculty to use vacation or sick time with variable allowance, and few employees utilized leave in the previous year.
Researchers identified fagopyrine, a naturally occurring compound in buckwheat, as a potential starting point for developing new AKT1-targeting drugs. The analysis revealed substantial variation in AKT1 expression across 33 cancer types, with increased expression linked to poorer outcomes in certain malignancies.
This comprehensive review synthesizes molecular mechanisms, current therapeutics, and emerging strategies in esophageal cancer. The findings highlight breakthroughs in immunotherapy and promising future directions in targeted therapies.
UChicago Medicine launches a groundbreaking clinical trial testing a new personalized cell therapy for advanced solid tumors, including ovarian cancer and melanoma. The treatment uses specially engineered T-cell receptors to detect hidden cancer proteins, expanding the number of cancers that can be targeted.
Families of children with B-cell acute lymphoblastic leukemia (B-ALL) experience substantial and lasting challenges, including household employment changes and marital status changes, beginning early after diagnosis. These challenges persist throughout treatment and have significant financial, social, and emotional impacts on families.
A study published in the journal CANCER found that young women with breast cancer experience delays in care, with lower income and younger age being the most common factors. These delays can lead to later stages of disease and more extensive treatment, impacting quality of life.
A new study finds that interventional radiologists (IRs) treat nearly 51% of Medicare patients with liver cancer, with the volume increasing over time. IRs deliver high-quality, high-impact care at a lower cost than oncologists, with faster recovery times and reduced hospital stays.
JMIR Cancer invites original research, viewpoints, and clinical submissions on breast cancer digital health innovations, focusing on patient-centered strategies, technological advancements, and innovative treatments. The call aims to improve screening accuracy, treatment protocols, and survivorship outcomes.
NCCN has published regional cancer treatment guidelines for the Philippines, tailored to the local setting and regulatory environment. The guidelines reflect collaborations with global organizations, including the International Gynecologic Cancer Society and the Philippine Society of Medical Oncology, to improve access to high-quality ...
A recent study found that fewer than 10% of people with Lynch syndrome take aspirin to prevent colorectal cancer, despite scientific evidence supporting its benefits. The study suggests that lower doses of aspirin may be a more practical and better-tolerated option for these patients.
Nuclear medicine is experiencing rapid growth with over 50 million procedures performed worldwide each year. EANM'26 will present the latest advances in nuclear medicine, molecular imaging, and radiopharmaceuticals, including theranostics and next-generation imaging technology.
The National Comprehensive Cancer Network hosted a summit on cancer prevention and screening, focusing on policy solutions and equity, innovation, and access. Key findings include the need to address barriers to access, the potential of new screening technologies to transform cancer detection, and the importance of value-based care mod...
Researchers identify key role of spatial niche in early gastric cancer initiation and progression, highlighting inflammation-associated spatial niche as fundamental regulatory unit. Targeting inflammation-associated spatial niches may enable earlier and more precise therapeutic strategies.
A new study found a higher prevalence of prior breast cancer in patients with gallbladder cancer compared to patients with other biliary tract cancers. The association was observed in two independent cohorts, with 25.7% of patients with gallbladder cancer having a history of breast cancer.
The new NCCN Guidelines for Pediatric Bone Sarcoma focus on Ewing sarcoma and other undifferentiated round cell sarcomas, aiming to provide clear medical roadmaps for patients and their families. With a 5-year survival rate of 81% for early-stage diagnosis, these guidelines can help ensure teenagers receive optimal treatment and support.
A new study by City of Hope and TGen found large differences in mutation rates between healthy individuals and cancer patients. The study suggests that individuals who accumulate mutations at a higher rate are more likely to develop cancer.
A new AI platform, Precision AI for Survivorship and Supportive Care, aims to personalize evidence-based support for cancer survivors navigating persistent side effects and other challenges after treatment. The platform uses machine-learning models to identify patterns associated with symptom burden and unplanned healthcare utilization...
Researchers at IIT have created nanoparticles that can heat up using infrared light, release antioxidant substances, and stimulate cells when activated by ultrasound. These multifunctional nanotubes have the potential to modulate cellular activity and be used in regenerative medicine and neurostimulation.
A large Medicare analysis found that depression is associated with higher cancer mortality, while psychotherapy soon after diagnosis reduces cancer risk. Patients with depression had a 21% lower risk of cancer-specific mortality after receiving psychotherapy within four weeks of their diagnosis.
Patients with small cell lung cancer and brain metastases lived 17.4 months with radiosurgery, compared to 8.6 months with whole brain treatment. Radiosurgery was associated with a 40% lower risk of death. The study challenges the long-standing reliance on whole brain treatment for SCLC brain metastases.
The human microbiome may influence cancer development, treatment response, and emerging precision-oncology strategies. Dysbiosis, or an imbalance in microbial communities, has been associated with several cancers, while favorable gut microbial profiles may support responses to immune checkpoint inhibitors.
A phase 3 trial found that delivering focused radiation therapy over three to five sessions after surgery for a large brain metastasis reduced cancer recurrence and improved survival. Patients who received multi-session treatment lived nine months longer than those treated in a single session without significantly increasing side effects.